Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-09-15 4:05 pm Sale | 13D | eFFECTOR Therapeutics, Inc. EFTR | COLUMN GROUP II LP | 4,091,734 6.6% | -217,595![]() (-5.05%) | View |
2023-01-13 4:50 pm Purchase | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 4,425,439 13.1% | 1,269,211![]() (+40.21%) | View |
2022-02-11 4:54 pm Sale | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 3,671,522 9.3% | -1,096,659![]() (-23.00%) | View |
2021-09-20 5:18 pm Sale | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 3,156,228 10.7% | -1,201,019![]() (-27.56%) | View |
2021-09-07 5:12 pm Purchase | 13D | eFFECTOR Therapeutics, Inc. EFTR | COLUMN GROUP II LP | 4,309,329 10.6% | 4,309,329![]() (New Position) | View |
2021-08-30 5:21 pm Sale | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 4,357,247 14.8% | -1,295,750![]() (-22.92%) | View |
2021-02-12 6:24 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 4,768,181 13.1% | 4,768,181![]() (New Position) | View |
2021-02-12 6:12 pm Sale | 13G | Gritstone bio, Inc. GRTS | COLUMN GROUP II LP | 0 0% | -3,102,934![]() (Position Closed) | View |
2020-11-04 4:52 pm Sale | 13G | Arcus Biosciences, Inc. RCUS | COLUMN GROUP II LP | 0 0% | -3,540,850![]() (Position Closed) | View |
2020-10-01 4:15 pm Sale | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 5,652,997 23.1% | -608,000![]() (-9.71%) | View |
2020-08-26 4:42 pm Sale | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 6,260,997 25.6% | -516,154![]() (-7.62%) | View |
2020-02-14 4:05 pm Unchanged | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 6,777,151 27.9% | 0 (Unchanged) | View |
2019-11-08 4:44 pm Purchase | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 6,777,151 31.8% | 6,777,151![]() (New Position) | View |
2019-02-13 4:47 pm Purchase | 13G | Gritstone bio, Inc. GRTS | COLUMN GROUP II LP | 3,102,934 10.7% | 3,102,934![]() (New Position) | View |
2019-02-13 4:44 pm Purchase | 13G | Arcus Biosciences, Inc. RCUS | COLUMN GROUP II LP | 3,540,850 8% | 3,540,850![]() (New Position) | View |